Quick Answer
Oric Pharmaceuticals, Inc. reported Total Assets of $408.89 million for fiscal year 2025.
Oric Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $408.89M | +49.2% |
| 2024 | $274.14M | +8.8% |
| 2023 | $252.01M | +2.0% |
| 2022 | $247.18M | -17.2% |
| 2021 | $298.64M | -0.1% |
| 2020 | $299.00M | +217.8% |
| 2019 | $94.09M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $431.19M | +42.7% | +24.3% |
| June 30, 2025 | $346.86M | +5.5% | +42.8% |
| March 31, 2025 | $242.86M | -30.8% | -11.4% |
| December 31, 2024 | $274.14M | +8.8% | -9.2% |
| September 30, 2024 | $302.07M | +10.1% | -8.2% |
| June 30, 2024 | $328.91M | +12.7% | -6.2% |
| March 31, 2024 | $350.79M | +54.8% | +39.2% |
| December 31, 2023 | $252.01M | +2.0% | -8.1% |
- Oric Pharmaceuticals, Inc. showed an increase of +49.2% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Oric Pharmaceuticals, Inc.’s total assets has grown by 334.6% (from $94.09 million to $408.89 million).
- The most recent figure is from Oric Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: